References 
  1. Lakhani SR EI, Schnitt SJ, Tan PH, van de Vijver MJ. WHO classification of tumours of the breast, vol. 4, 4th edn. Geneva, Switzerland; WHO Press 2012.
  2. Weigelt B, Eberle C, Cowell CF, Ng CK, Reis-Filho JS. Metaplastic breast carcinoma: more than a special type. Nat Rev Cancer. 2014;14(3):147–8.
  3. Sinn H, Kreipe H. A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd Edition. Breast Care. 2013. 8(2): 149–154.
  4.  ̵‌McMullen ER, Zoumberos NA, Kleer CG. Metaplastic breast carcinoma: update on histopathology and molecular alterations. Arch Pathol Lab Med. 2019;143(12):1492–6.
  5. Wong W, Brogi E, Reis-Filho JS, et al. Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma. npj Breast Cancer. 2021; 7, 96
  6. Reddy TP,  Rosato RR, Li X, et al. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res, 2020; 22, 121.
  7. Nelson RA, Guye ML, Luu T, Lai LL. Survival outcomes of metaplastic breast cancer patients: results from a US population-based analysis. Ann Surg Oncol. 2015; 22(1): 24–31.
  8. Thapa B, Arobelidze S, Clark BA, Xuefei J, Daw H, Cheng Y C, et al. Metaplastic Breast Cancer: Characteristics and Survival Outcomes. Cureus, 2022; 14(8). e28551
  9. Nagao T, Kinoshita T, Hojo T, Tsuda H, Tamura K, Fujiwara Y. The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: the relationship between the outcome and the clinicopathological characteristics. Breast. 2012; 21(3): 289-95.
  10. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol. 2007; 14(1): 166-73.
  11. Lai HW, Tseng LM, Chang TW, Kuo YL, Hsieh CM, Chen ST, et. al. The prognostic significance of metaplastic carcinoma of the breast (MCB)–a case controlled comparison study with infiltrating ductal carcinoma. Breast. 2013; 22(5): 968-73.
  12. Morgan E, Suresh A, Ganju A, Stover D.S., Wesolowski R, Sardesai S. World J Surg Oncol. 2020; 18: 11.
  13. Zhou X, Wu X, Wang L, Guo J, Wu Q, Song W, et al. Metaplastic breast carcinoma: a retrospective study of 26 cases. Int J Clin Exp Pathol. 2021 Mar 1; 14(3): 355-362
  14. Weigelt B, Kreike B, Reis-Filho JS. Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res Treat 2009; 117: 273–280.
  15. van Deurzen C.H, Lee A.H, Gill MS, Menke-Pluijmers MB, Jager A, Ellis IO, et al, Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation?. J. Pathol. 2011, 224: 434-437.
  16. Leddy R, Irshad A, Rumboldt T, Cluver A, Campbell A, Ackerman S. Review of metaplastic carcinoma of the breast: imaging findings and pathologic features. J Clin Imaging Sci 2012; 2:21.
  17. Beatty JD, Atwood M, Tickman R, Reiner M, Metaplastic breast cancer: clinical significance. Am J Surg 2006, 191: 657–664.
  18. Tan QT, Chuwa EW, Chew SH, Lim-Tan SK, Lim SH. Low-grade adenosquamous carcinoma of the breast: a diagnostic and clinical challenge. Int J Surg. 2015; 19: 22–26.
  19. Rosen PP, Ernsberger D. Low-grade adenosquamous carcinoma: a variant of metaplastic mammary carcinoma. Am J Surg Pathol. 1987; 11(5): 351–358.
  20. Tseng WH, Martinez SR, Metaplastic Breast Cancer: To Radiate or Not to Radiate?, Ann Surg Oncol 18, 2011, 94–103
  21. Li Y, Chen M, Pardini B, Dragomir MP, Lucci A, Calin GA. The role of radiotherapy in metaplastic breast cancer: a propensity score-matched analysis of the SEER database. J Transl Med. 2019; 17(1): 318.
  22. Böler DE, Kara H, Sağlıcan Y, Tokat F, Uras C, Metaplastic carcinoma of the breast: A case series and review of the literature. J Onc Sci 2016, 2(2-3): 38-42.